TARAHealthcareMicro-Cap

Protara Therapeutics, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Protara Therapeutics, Inc. (TARA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are TARA insiders buying or selling?

Protara Therapeutics, Inc. insiders reported 20 open-market buys ($7.2M) and 31 sells ($4.6M) across 51 Form 4 filings — a net buying position of $2.6M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 1, 2026)

Total Form 4 filings
51
SEC EDGAR
Insider filers
8
Insider buys (20)
$7.2M
Insider sells (31)
$4.6M

Insider sentiment

Net buying

Net insider flow of $2.6M in net buying.

Recent TARA insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 1, 2026Jesse SheffermanCEO and PresidentSale215.7K$4.09$882.2K
Apr 9, 2026Jacqueline ZummoChief R&D OfficerSale1.1K$5.40$6.1K
Apr 2, 2026Jacqueline ZummoChief R&D OfficerSale22.6K$5.26$118.9K
May 19, 2025Richard S LevyDirectorPurchase20.0K$3.19$63.8K
May 16, 2025Richard S LevyDirectorPurchase20.0K$3.19$63.8K
Mar 28, 2025Jacqueline ZummoChf Scientific Operations OffSale21.2K$4.53$96.1K
Sep 13, 2024Opaleye Management Inc.10% OwnerSale158.9K$1.71$271.7K
Sep 10, 2024Opaleye Management Inc.10% OwnerSale62.0K$1.84$114.3K
Jul 18, 2024Opaleye Management Inc.10% OwnerSale11.4K$2.44$27.8K
Jul 11, 2024Opaleye Management Inc.10% OwnerSale74.6K$2.36$175.8K
Jul 3, 2024Opaleye Management Inc.10% OwnerSale8.3K$2.12$17.6K
Jun 28, 2024Opaleye Management Inc.10% OwnerSale64.6K$2.21$142.5K
Jun 27, 2024Opaleye Management Inc.10% OwnerSale12.7K$2.26$28.7K
May 31, 2024Opaleye Management Inc.10% OwnerSale15.1K$2.92$44.0K
May 23, 2024Opaleye Management Inc.10% OwnerSale42.8K$3.05$130.4K
May 17, 2024Opaleye Management Inc.10% OwnerSale70.9K$3.25$230.3K
May 10, 2024Opaleye Management Inc.10% OwnerSale182.3K$3.11$567.0K
Dec 30, 2022Opaleye Management Inc.10% OwnerPurchase15.5K$2.71$41.9K
Sep 15, 2022Opaleye Management Inc.10% OwnerPurchase23.9K$3.93$93.8K
Aug 15, 2022Jesse SheffermanCEO and PresidentPurchase9.1K$3.84$34.8K
Apr 15, 2022Opaleye Management Inc.10% OwnerPurchase10.1K$4.78$48.5K
Apr 8, 2022Opaleye Management Inc.10% OwnerPurchase10.1K$4.78$48.5K
Mar 16, 2022Luke M BesharDirectorPurchase10.0K$4.25$42.5K
Mar 14, 2022Luke M BesharDirectorPurchase10.0K$4.46$44.6K
Jan 31, 2022Opaleye Management Inc.10% OwnerPurchase24.0K$4.96$119.3K

Showing the 25 most recent of 51 Form 4 filings for Protara Therapeutics, Inc..

Most active TARA insiders

  • Opaleye Management Inc.24 filings
  • Randall Marshall16 filings
  • Jacqueline Zummo3 filings
  • Jesse Shefferman2 filings
  • Luke M Beshar2 filings

Ask anything about TARA insider activity

Use Trabud's AI agent to query Protara Therapeutics, Inc.'s Form 4 history in plain English — "Show me TARA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

TARA insider trading FAQ

Are Protara Therapeutics, Inc. insiders buying or selling?

Across 51 SEC Form 4 filings, Protara Therapeutics, Inc. (TARA) insiders reported 20 open-market purchases totaling $7.2M and 31 sales totaling $4.6M. That is a net buying position of $2.6M.

How many insiders trade TARA stock?

8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Protara Therapeutics, Inc.. The most recent filing was accepted on Jul 1, 2026.

Where does Trabud get TARA insider trading data?

All TARA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content